Autoimmune, Immune-mediated and Collagen Vascular Diseases
These are the AT&T CarePlus covered procedures and services effective January 1, 2023. Prior approval is required, please contact CarePlus customer care at 1-877-261-3340.
Autologous Stem Cell (including bone marrow) Transplant w/HDC
For additional (non-cancer) indications:
- Recessive Dystrophic Epidermolysis Bullosa (rDEB)
- Systemic Lupus Erythematosus
- Systemic Sclerosis
- Rheumatoid Arthritis
- Juvenile Rheumatoid Arthritis
- Dermatomyositis
- Polymyositis
- Crohn’s Disease
- Ulcerative Colitis
Intravenous Immune Globulin (IVIG)
For treatment of specific conditions consistent with guidelines published by recognized expert organizations (i.e., IOM, NICE, AAAAI) and medical specialty societies.
Low-Level Laser Therapy (LLLTI) to Treat Mouth Lesions Caused by Pemphigus Vulgaris
Use of low-power lasers to treat lesions in the mouth caused by pemphigus vulgaris.
Note: This service is effective 7/1/2018.
Off-label Use of Selzentry (maraviroc)
An HIV treatment, for the prevention of graft-versus-host during stem cell transplants.
Prochymal (remestemcel-L)
For treatment of acute graft-versus-host disease.
Rituxan (rituximab) and Truxima (rituximab-abbs) (Anti B-Cell) Therapy (Covered only for participants who do not have coverage for this service under their Base Medical Program)
For expanded list of indications-immune modulation, including:
- Systemic Lupus Erythematosus
- Systemic Sclerosis